The integration of artificial intelligence into clinical workflows demands architectures that dynamically adapt treatment policies to real-time patient data while ensuring seamless interoperability with existing healthcare systems. This conceptual manuscript proposes a novel reinforcement-governed treatment policy architecture (RGTPA) designed to orchestrate adaptive decision-making in clinical environments. Drawing from reinforcement learning principles, the RGTPA embeds policy optimization mechanisms within electronic health record (EHR) ecosystems, facilitating continuous feedback loops that refine treatment recommendations without empirical training. The architecture comprises layered components for state representation, reward modeling, and policy governance, emphasizing interoperability standards like HL7 FHIR for data exchange. Theoretical analysis highlights how reinforcement signals mitigate decision latency in high-stakes settings such as intensive care, while governance modules monitor for policy drift. By synthesizing literature on clinical AI systems and decision support pipelines, this work outlines infrastructural pathways for embedding RGTPA into workflows, addressing challenges in human-AI collaboration and regulatory compliance. Conceptual formulas illustrate risk propagation and governance load, providing interpretive tools for system designers. Ultimately, RGTPA advances theoretical frameworks for AI-driven healthcare, promoting resilient, adaptive treatment policies that align with clinical imperatives.
Septic shock, defined as sepsis with persistent hypotension despite adequate fluid resuscitation and requiring vasopressors, has a mortality rate of 30–50% despite modern treatment. Intravenous fluids remain the cornerstone of early therapy, with guidelines recommending at least 30 mL/kg of crystalloids within the first three hours. However, both insufficient and excessive fluid administration can be harmful, making individualized, data-driven management essential. Reinforcement learning (RL) has been proposed to optimize fluid and vasopressor dosing in sepsis using retrospective ICU data. While models such as the AI Clinician suggest potential survival benefits, they often prioritize long-term outcomes like mortality and overlook short-term harms such as fluid overload and organ injury, raising safety concerns. Safety constraints and harm-aware reward design are essential in RL systems for septic shock. Pure outcome optimization is insufficient, and clinical AI must include mechanisms to prevent unsafe actions and ensure adherence to safety limits. Offline RL is vulnerable to distributional shift and unsafe extrapolation. Reward functions focused only on survival ignore acute complications, leading to unsafe policies. Human-in-the-loop oversight is necessary to maintain clinical accountability and enable intervention. RL systems should include action constraints, conservative learning with uncertainty estimation, and reward penalties for fluid overload indicators. Regulatory bodies and journals should require safety validation, and clinicians must retain override authority and transparency in decision-making. RL in septic shock management must prioritize patient safety through constraints, harm-aware rewards, and clinical oversight. Without these safeguards, deployment risks patient harm and loss of trust in clinical AI.